Proteo Biotech AG
- ISIN US74369R1005
- Land Deutschland
Unternehmensprofil
Proteo Inc., together with its subsidiary, is engaged in the development of pharmaceuticals based on the body’s own tools and weapons to fight inflammatory diseases. Proteo is a clinical stage drug development company and intends to develop, promote and market pharmaceuticals and other biotech products. The Company’s focus is on the development of anti-inflammatory treatments for rare diseases with significant unmet needs.